Shigeji Katayama

565 total citations
18 papers, 453 citations indexed

About

Shigeji Katayama is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Shigeji Katayama has authored 18 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Shigeji Katayama's work include Toxin Mechanisms and Immunotoxins (5 papers), Herpesvirus Infections and Treatments (5 papers) and Virus-based gene therapy research (4 papers). Shigeji Katayama is often cited by papers focused on Toxin Mechanisms and Immunotoxins (5 papers), Herpesvirus Infections and Treatments (5 papers) and Virus-based gene therapy research (4 papers). Shigeji Katayama collaborates with scholars based in . Shigeji Katayama's co-authors include Toshiaki Ohgitani, Kenji Oda, Masayuki Yoshikawa, Hisashi Matsuda, Toshiyuki Murakami, Yukio Shimizu, Takashi Matsuba, B. K. Baek, Masami Yamanaka and Chihiro Sugimoto and has published in prestigious journals such as Journal of Clinical Microbiology, Vaccine and Biological Chemistry.

In The Last Decade

Shigeji Katayama

18 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeji Katayama 9 182 131 85 77 70 18 453
Toshiaki Ohgitani Japan 12 194 1.1× 151 1.2× 106 1.2× 66 0.9× 63 0.9× 23 512
Chenwen Xiao China 10 147 0.8× 139 1.1× 133 1.6× 135 1.8× 127 1.8× 22 622
Zahid Iqbal Rajput China 11 128 0.7× 128 1.0× 210 2.5× 204 2.6× 116 1.7× 18 657
Ning Shi China 16 155 0.9× 78 0.6× 188 2.2× 35 0.5× 52 0.7× 46 576
Naíla Cannes do Nascimento United States 16 143 0.8× 37 0.3× 165 1.9× 191 2.5× 150 2.1× 43 625
Robert C. Layton United States 14 128 0.7× 61 0.5× 76 0.9× 26 0.3× 311 4.4× 23 671
Kun Shi China 14 88 0.5× 34 0.3× 145 1.7× 114 1.5× 33 0.5× 51 532
Mohammad Hossein Razi Jalali Iran 12 50 0.3× 44 0.3× 147 1.7× 276 3.6× 54 0.8× 67 522
Fernando Silveira Uruguay 11 146 0.8× 150 1.1× 76 0.9× 63 0.8× 26 0.4× 21 384
John C. Meade United States 14 222 1.2× 42 0.3× 45 0.5× 123 1.6× 70 1.0× 23 608

Countries citing papers authored by Shigeji Katayama

Since Specialization
Citations

This map shows the geographic impact of Shigeji Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeji Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeji Katayama more than expected).

Fields of papers citing papers by Shigeji Katayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeji Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeji Katayama. The network helps show where Shigeji Katayama may publish in the future.

Co-authorship network of co-authors of Shigeji Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeji Katayama. A scholar is included among the top collaborators of Shigeji Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeji Katayama. Shigeji Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ito, Toshihiro, et al.. (2010). Genetic and Antigenic Characterization of Newly Isolated Bovine Toroviruses from Japanese Cattle. Journal of Clinical Microbiology. 48(5). 1795–1800. 16 indexed citations
3.
AMIMOTO, Katsuhiko, et al.. (2002). Protective Effect of Clostridium septicum Alpha-Toxoid Vaccine against Challenge with Spores in Guinea Pigs.. Journal of Veterinary Medical Science. 64(1). 67–69. 18 indexed citations
4.
AMIMOTO, Katsuhiko, et al.. (2001). Protective Effects of Clostridium sordellii LT and HT Toxoids against Challenge with Spores in Guinea Pigs.. Journal of Veterinary Medical Science. 63(8). 879–883. 9 indexed citations
5.
Oda, Kenji, Hisashi Matsuda, Toshiyuki Murakami, et al.. (2000). Adjuvant and Haemolytic Activities of 47 Saponins Derived from Medicinal and Food Plants. Biological Chemistry. 381(1). 67–74. 229 indexed citations
6.
Kitajima, Takashi, Eiji Oishi, Katsuhiko AMIMOTO, et al.. (2000). Quantiative Diversity of 67kDa Protective Antigen among Serovar 2 Strains of Erysipelothrix rhusiopathiae and Its Implication in Protective Immune Response.. Journal of Veterinary Medical Science. 62(10). 1073–1077. 4 indexed citations
7.
Katayama, Shigeji, et al.. (1999). Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice. Vaccine. 17(20-21). 2733–2739. 20 indexed citations
8.
Katayama, Shigeji, et al.. (1999). A New Quantitative Method for Rabies Virus by Detection of Nucleoprotein in Virion Using ELISA.. Journal of Veterinary Medical Science. 61(4). 411–416. 18 indexed citations
9.
Taharaguchi, Satoshi, et al.. (1998). Nucleotide Sequence of the Spike Protein of a Canine Coronavirus, Strain 5821. Journal of the Japan Veterinary Medical Association. 51(5). 251–255. 3 indexed citations
10.
Katayama, Shigeji, et al.. (1998). Efficacy of a Mixed Glycoprotein Vaccine against Pseudorabies in Pregnant Sows.. Journal of Veterinary Medical Science. 60(1). 23–27. 6 indexed citations
11.
Katayama, Shigeji, et al.. (1998). Influence of Cell Surface Glycoprotein gC Produced by Pseudorabies Virus on Cytopathic Effect.. Journal of Veterinary Medical Science. 60(8). 905–909. 1 indexed citations
12.
Katayama, Shigeji, et al.. (1997). Protective Effect of Glycoprotein gC-Rich Antigen against Pseudorabies Virus.. Journal of Veterinary Medical Science. 59(8). 657–663. 14 indexed citations
13.
Kitajima, Takashi, et al.. (1995). Protective Efficacy of Cell-Free-Antigen of Actinobacillus pleuropneumoniae in Mice.. Journal of Veterinary Medical Science. 57(4). 727–731. 3 indexed citations
14.
Oishi, Eiji, et al.. (1995). Protective Effect of the Combined vaccine Prepared from Cell-Free-Antigen of Actinobacillus pleuropneumoniae Serotypes 1,2 and 5 in Pigs.. Journal of Veterinary Medical Science. 57(6). 1125–1128. 8 indexed citations
15.
Tanaka, Masayuki, Sadao Onoe, Takashi Matsuba, et al.. (1993). Detection of Theileria sergenti infection in cattle by polymerase chain reaction amplification of parasite-specific DNA. Journal of Clinical Microbiology. 31(10). 2565–2569. 75 indexed citations
16.
Tsuchida, Akira, et al.. (1992). Protection from Pseudorabies Virus Challenge in Mice by a Combination of Purified gII, gIII and gVI Antigens.. Journal of Veterinary Medical Science. 54(3). 447–452. 8 indexed citations
17.
Katayama, Shigeji, et al.. (1991). The Adsorption of Pseudorabies Virus Glycoprotein gIII to the Host Cell.. Journal of Veterinary Medical Science. 53(5). 957–958. 3 indexed citations
18.
Matsuda, Atsunori, et al.. (1991). Characterization of Protective Viral Glycoproteins for Pseudorabies Virus Infection.. Journal of Veterinary Medical Science. 53(4). 737–741. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026